ArticleOncotarget2019

Efficacy of a third-generation oncolytic herpes simplex virus in neuroendocrine tumor xenograft models.

Hideyuki Matsushima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.